Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05065554
Title ACALA-R In Anti-MAG Neuropathy Mediated Neuropathy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jorge J. Castillo, MD
Indications

Waldenstroem's macroglobulinemia

Therapies

Acalabrutinib + Rituximab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.